Effect of age, degree and distribution of adiposity on the prevalence of the metabolic syndrome in a cohort of obese Italian women

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 225-233

  Sartorio, Alessandro ^a   Agosti, Fiorenza ^a   Adorni, Fulvio ^b   Pera, Franca ^a   Lafortuna, Claudio L ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Blood pressure; Fasting plasma glucose; HDL cholesterol; Metabolic syndrome; Obesity; Triglycerides

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONSENSUS SEQUENCE; DISEASE CLASSIFICATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERNATIONAL COOPERATION; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PREVALENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; ITALY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; WAIST-HIP RATIO;

EID: 34748883223     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.005     Document Type: Article

References (38)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
3. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
4. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
5. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
6. Reynolds K., and He J. Epidemiology of the metabolic syndrome. Am. J. Med. Sci. 330 (2005) 273-279
7. World Health Organization. Definition Diagnosis and Classification of Diabetes Mellitus and its Complications (1999), WHO, Department of Noncommunicable Disease Surveillance, Geneva
8. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EIGIR). Diabet. Med. 15 (1998) 539-553
9. Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
10. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9 (2003) 237-252
11. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome, Available from http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf [last accessed September 18, 2006].
12. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 25 112 (2005) 2735-2752
13. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163 (2003) 427-436
14. Gimeno R.E., and Klaman L.D. Adipose tissue as an active endocrine organ: recent advances. Curr. Opin. Pharmacol. 5 (2005) 122-128
15. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, The evidence report, NIH publication no. 98-4083, National Institute of Health, 1998.
16. World Health Organization, Measuring obesity-Classification and description of anthropometric data, Report on a WHO consultation on the epidemiology of obesity, EUR/ICP/NUT 125, WHO regional office for Europe, Warsaw, 1987.
17. Sowers J.R. Obesity as a cardiovascular risk factor. Am. J. Med. 115 (2003) 37S-41S
18. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R.C., et al. Metabolic syndrome: epidemiology and more extensive phenotypic description cross-sectional data from the Bruneck Study. Int. J. Obes. 27 (2003) 1283-1289
19. Miccoli R., Bianchi C., Odoguardi L., Penno G., Caricato F., Giovannitti M.G., et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15 (2005) 250-254
20. Liese A.D., Mayer-Davis E.J., and Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol. Rev. 20 (1998) 157-172
21. Chang A.M., and Halter J.B. Aging and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E7-E12
22. Karakelides H., and Sreekumaran Nair K. Sarcopenia of aging and its metabolic impact. Curr. Top. Dev. Biol. 68 (2005) 123-148
23. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
24. Hutley L., and Prins J.B. Fat as an endocrine organ: relationship to the metabolic syndrome. Am. J. Med. Sci. 330 (2005) 280-289
25. Pi-Sunyer F.X. The epidemiology of central fat distribution in relation to disease. Nutr. Rev. 62 (2004) S120-S126
26. Hartz A.J., Rupley D.C., and Rimm A.A. The association of girth measurements with disease in 32,856 women. Am. J. Epidemiol. 119 (1984) 71-80
27. Goodpaster B.H., Krishnaswami S., Harris T.B., Katsiaras A., Kritchevsky S.B., Simonsick E.M., et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165 (2005) 777-783
28. Rexrode K.M., Carey V.J., Hennekens C.H., Walters E.E., Colditz G.A., Stampfer M.J., et al. Abdominal adiposity and coronary heart disease in women. JAMA 280 (1998) 1843-1848
29. Taylor R.W., Keil D., Gold E.J., Williams S.M., and Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am. J. Clin. Nutr. 67 (1998) 44-49
30. Molarius A., Seidell J.C., Sans S., Tuomilehto J., and Kuulasmaa K. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int. J. Obes. Relat. Metab. Disord. 23 (1999) 116-125
31. C.L. Lafortuna, F. Adorni, F. Agosti, A. Sartorio, Factor analysis of metabolic syndrome components in obese women, Nutr. Metab. Cardiovasc. Dis., in press.
32. Carey D.G., Jenkins A.B., Campbell L.V., Freund J., and Chisholm D.J. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45 (1996) 633-638
33. Accili D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53 (2004) 1633-1642
34. Reaven G.M., Lithell H., and Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334 (1996) 374-381
35. McDougall J., Litzau K., Haver E., Saunders V., and Spiller G.A. Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat, strictly vegetarian diet. J. Am. Coll. Nutr. 14 (1995) 491-496
36. Diehl H.A. Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience. Am. J. Cardiol. 82 (1998) 83T-87T
37. Sjostrom M., Karlsson A.B., Kaati G., Yngve A., Green L.W., and Bygren L.O. A four-week residential program for primary health care patients to control obesity and related heart risk factors: effectivge application of principles of learning and lifestyle change. Eur. J. Clin. Nutr. 53 suppl. 2 (1999) S72-S77
38. Sartorio A., Lafortuna C.L., Vangeli V., Tavani A., Bosetti C., and La Vecchia C. Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur. J. Clin. Nutr. 55 (2001) 865-869